Biotest Pharmaceuticals names new chief executive
Jordan Siegel is promoted from chief financial officer
BPC’s interim chief executive, Georg Floss, will return to Germany on 30 April to assume the role of global head of operations at Biotest AG.
Siegel has been BPC’s senior vice president, finance and chief financial officer since its inception in 2007.
BPC researches, develops and manufactures biotherapeutic products for immunology and haematology. The firm is a leader in the collection of source plasma and is currently involved in the development of plasma protein products in the field of Primary Immune Deficiency (PID) and various hyperimmune (IG) products. It owns and manages 12 plasmapherisis centres across the US and a manufacturing facility in Boca Raton, Florida.
You may also like
Manufacturing
WLS introduces PR-12 and PR-24 plunger rod insertion and labelling systems
By improving reliability and streamlining production, the PR-12 and PR-24 help pharmaceutical manufacturers and contract packers protect product quality and reduce waste while maximising operational efficiencies
Pharmaceutical
Azelis strengthens its footprint in Italy with the acquisition of Azienda Chimica e Farmaceutica (‘ACEF’)
Azelis is pleased to announce that it has acquired 100% of the shares of Azienda Chimica e Farmaceutica (‘ACEF’), a distributor of speciality raw materials and ingredients for the cosmetic, nutraceutical, galenic and pharma industries in Italy
Manufacturing
Atlas Copco expands oil-free compressor range to support critical pharmaceutical air quality standards
Atlas Copco has expanded its oil-free compressor portfolio with cutting-edge models engineered to exceed pharmaceutical air quality standards and improve energy efficiency across critical manufacturing environments